Due to the inhibition of PTP1B activity, the preventive action of signaling pathways that support cell survival is improved, resulting in compensatory mechanisms like inflammation and liver damage associated with NAFLD. This evidence concerns the gene PTPN1 and metabolic dysfunction-associated steatotic liver disease.